Consultation responses

Pharmacist

The Society frequently responds to consultations issued by a range of organisations including Government Departments, regulatory bodies and other healthcare and professional bodies.

Organisations running consultations seek views and feedback on proposals to change policy, draft guidance, standards documents and other call for evidence.

We respond on behalf of the membership to ensure that pharmacy has a clear, strong voice in all discussions which affect healthcare and pharmacy. Our aim is to ensure that the views of members and experts within the profession are reflected in our responses to consultations, therefore we work in partnership with expert groups to provide a coordinated response to consultations where appropriate.

Current consultations


Completed consultation responses


Members who have any questions about consultations can contact our support team.

National Institute of Health and Clinical Excellence (NICE) 

All healthcare professionals in England are required to comply with guidance and quality standards from the National Institute of Health and Clinical Excellence (NICE). The RPS is registered as a stakeholder for the development of all NICE guidance, quality standards and technology appraisals. We work with a wide range of specialist partnership groups to ensure that the profession’s views and expertise influence and inform the development of NICE guidance and quality standards. A list of current NICE consultations is available on the NICE website and we encourage members with relevant expertise in the topics under review to get involved by contacting us on support@rpharms.com.

Scottish Intercollegiate Guidelines Network

The Scottish Intercollegiate Guidelines Network (SIGN) develops evidence based clinical practice guidelines for the National Health Service (NHS) in Scotland.

All Wales Medicines Strategy Group (AWMSG)

The Welsh Assembly Government produces health guidance for Wales. The WAG is advised on strategic medicines management and prescribing by the All Wales Medicines Strategy Group (AWMSG)